{
  "documents": [
    {
      "id": "cluster_0_doc1",
      "content": "Ms. Aaliyah Khoury (PATIENT_ID 7R9T2P4E) initiated a prior authorization request for vestibular schwannoma surgery at Cedars-Sinai Medical Center, referencing policy XQR88932. Her neurologist Dr. Helena Voss noted significant progression of bilateral acoustic neuromas despite previous gamma knife treatments. The surgical team highlighted concerns about cerebrospinal fluid leakage risks given the patient's history of arachnoid cysts.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_0_doc2",
      "content": "Claims processing memo dated 2023-09-15: Policy XQR88932 requires secondary review for procedures exceeding $250k. Patient Khoury's vestibular schwannoma resection was flagged due to potential overlap with investigational gene therapy protocols. The medical director requested additional operative notes documenting tumor size measurements in three dimensions.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_0_doc3",
      "content": "Research bulletin from Cedars-Sinai Neurootology Department: Current outcomes study tracking patients (n=14) with bilateral vestibular schwannomas and comorbid arachnoid cysts. Preliminary data shows 38% CSF leak rate vs 12% in unilateral cases. Study coordinator Kiyomi Takahashi can be reached at neuro.research@cedars.net.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_0_doc4",
      "content": "Patient satisfaction survey completed by Aaliyah Khoury (DOB 1985-07-22) rated pre-surgical coordination 2/5 stars, citing delays in insurance approvals. Notable comment: 'Three-week wait for authorization caused worsening balance issues.' Survey ID S-2023-09-Q4-8823 was processed by claims advocate Rafael Amari at the Westwood office.",
      "metadata": {
        "format": "patient_survey"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_0",
    "cluster_risk": "HIGH",
    "content_summary": "Complex case of bilateral vestibular schwannomas with insurance authorization challenges and research implications",
    "person": {
      "entities": [
        [
          "Aaliyah Khoury",
          "NAME"
        ],
        [
          "7R9T2P4E",
          "PATIENT_ID"
        ],
        [
          "neuro.research@cedars.net",
          "EMAIL"
        ],
        [
          "1985-07-22",
          "BIRTHDATE"
        ],
        [
          "XQR88932",
          "PROCESS_ID"
        ],
        [
          "vestibular schwannoma",
          "MEDICAL_CONDITION"
        ],
        [
          "Cedars-Sinai Medical Center",
          "LOCATION"
        ],
        [
          "arachnoid cysts",
          "MEDICAL_CONDITION"
        ],
        [
          "2023-09-15",
          "EVENT_DATE"
        ],
        [
          "gamma knife treatments",
          "EVENT"
        ]
      ]
    },
    "questions": [
      {
        "q": "Which two preexisting conditions made Aaliyah Khoury's vestibular schwannoma surgery higher risk?",
        "a": "Bilateral vestibular schwannomas and arachnoid cysts",
        "sources": [
          "cluster_0_doc1"
        ],
        "type": "specific"
      },
      {
        "q": "What link was identified between research protocols and the XQR88932 policy review?",
        "a": "Potential overlap with investigational gene therapy protocols",
        "sources": [
          "cluster_0_doc2"
        ],
        "type": "general"
      },
      {
        "q": "How did the CSF leak rates compared between unilateral and bilateral tumor patients at Cedars-Sinai?",
        "a": "38% in bilateral cases vs 12% in unilateral cases",
        "sources": [
          "cluster_0_doc1",
          "cluster_0_doc3"
        ],
        "type": "specific"
      },
      {
        "q": "What two operational issues emerged regarding high-cost neurosurgical approvals in September 2023?",
        "a": "Secondary reviews over $250k and documentation requirements for tumor measurements",
        "sources": [
          "cluster_0_doc2",
          "cluster_0_doc4"
        ],
        "type": "general"
      }
    ]
  }
}